Form4insider filings, from the source

Company · CIK 0001743881 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

BridgeBio Pharma, Inc. · BBIO

Insider activity reported against this company. All insider holders · Files at: EIDX. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market activity at this companybuys $0 · 0sales $19.2M · 5net −$19.2M
$10k$10k$1M$1M$100M$100MbuyssalesJun 28Jul 13Jul 28Aug 13Aug 28Sep 12Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 17, 2026 SForm 4 →Sep 21, 6:21 pm EDTNeil KumarChief Executive Officer, Director10,000$69.08$690,847495,686−1.98%10b5-1
Aug 18, 2026 SForm 4 →Aug 20, 4:31 pm EDTNeil KumarChief Executive Officer, Director44,980$82.86$3,727,251505,686−8.17%10b5-1
Aug 16, 2026 FForm 4 →Aug 18, 6:02 pm EDTThomas TrimarchiPresident and CFO22,781$79.86$1,819,291336,529—
Aug 16, 2026 FMForm 4 →Aug 18, 6:02 pm EDTNeil KumarChief Executive Officer, Director107,454$79.86$2,893,887278,307—
Aug 16, 2026 FForm 4 →Aug 18, 6:02 pm EDTMaricel ApuliChief Accounting Officer4,714$79.86$376,460122,687—
Jul 30, 2026 SForm 4 →Aug 3, 4:20 pm EDTMaricel ApuliChief Accounting Officer2,000$80.06$160,120127,401−1.55%10b5-1
Jul 9, 2026 SForm 4 →Jul 13, 4:41 pm EDTAndrea EllisDirector17,167$84.00$1,442,02822,579−43.2%10b5-1
Jul 9, 2026 MForm 4 →Jul 13, 4:41 pm EDTAndrea EllisDirector17,167$16.75$287,54739,746—10b5-1
Jul 9, 2026 SForm 4 →Jul 13, 4:40 pm EDTJennifer E. CookDirector148,589$88.54$13,156,0088,383−94.7%10b5-1
Jul 9, 2026 MForm 4 →Jul 13, 4:40 pm EDTJennifer E. CookDirector148,589$24.96$3,708,335156,972—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 16, 2026 MForm 4 →Aug 18, 6:02 pm EDTNeil KumarChief Executive Officer, Director71,217——91,274—
Jul 9, 2026 MForm 4 →Jul 13, 4:41 pm EDTAndrea EllisDirector17,167——17,167—10b5-1
Jul 9, 2026 MForm 4 →Jul 13, 4:40 pm EDTJennifer E. CookDirector148,589——0—10b5-1

Filed by this entity as an insider elsewhere — common stock

No reported common-stock activity in this period.

Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.